Global Market for Contract Research Organization (CRO) Services
Report Scope:
The Global CRO market is identified in this report, along with all major global CRO companies. The total CRO market is broken out globally and by geographic region. All major therapeutic areas covered by CROs in the clinical trial process are detailed. The service areas provided by CROs are extensively covered, as well. The phases of the clinical trial process and the role provided by CROs are detailed in this report, as well. The current report will provide detailed examination of CRO services, analyzing market trends for CRO services with data from 2020, estimates from 2021 and projections of CAGR through 2026 (forecast period 2021-2026).
This report provides detailed analysis of the top CROs and evolving roles in the clinical trial process. Faced with the rapid development of new therapies, pharmaceutical companies increasingly turn to CROs. CRO expertise within specific therapeutic areas and experience with new and adaptive study design protocols, can reduce costs and study duration. With typical clinical trials costing nearly $2.5 billion and spanning over a decade, from initial testing to Phase IV and post market approval, a thriving market exists to lower these costs and timelines. CROs are expected to continue to play an increasing role in many facets of the clinical trial process. Oncology, neurology, cardiovascular, metabolism-diabetes, vaccines and other rapidly growing therapeutic areas that have a significant number of drugs in the clinical trial process are detailed in this report.
Strong demand for CROs leads to heightened market valuations and to a plethora of blockbuster mergers and acquisitions (M&As). M&As led to a few powerful companies with expertise across many areas of the clinical trial process. Niche players are still playing a critical role. Emerging trends and changing dynamics within the CRO industry are analyzed, in detail, in this report.
Report Includes:
The Global CRO market is identified in this report, along with all major global CRO companies. The total CRO market is broken out globally and by geographic region. All major therapeutic areas covered by CROs in the clinical trial process are detailed. The service areas provided by CROs are extensively covered, as well. The phases of the clinical trial process and the role provided by CROs are detailed in this report, as well. The current report will provide detailed examination of CRO services, analyzing market trends for CRO services with data from 2020, estimates from 2021 and projections of CAGR through 2026 (forecast period 2021-2026).
This report provides detailed analysis of the top CROs and evolving roles in the clinical trial process. Faced with the rapid development of new therapies, pharmaceutical companies increasingly turn to CROs. CRO expertise within specific therapeutic areas and experience with new and adaptive study design protocols, can reduce costs and study duration. With typical clinical trials costing nearly $2.5 billion and spanning over a decade, from initial testing to Phase IV and post market approval, a thriving market exists to lower these costs and timelines. CROs are expected to continue to play an increasing role in many facets of the clinical trial process. Oncology, neurology, cardiovascular, metabolism-diabetes, vaccines and other rapidly growing therapeutic areas that have a significant number of drugs in the clinical trial process are detailed in this report.
Strong demand for CROs leads to heightened market valuations and to a plethora of blockbuster mergers and acquisitions (M&As). M&As led to a few powerful companies with expertise across many areas of the clinical trial process. Niche players are still playing a critical role. Emerging trends and changing dynamics within the CRO industry are analyzed, in detail, in this report.
Report Includes:
- 35 tables
- An updated review of the global markets for in vitro toxicity testing and technologies under development
- Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for in vitro toxicity testing over the next five years (2021 to 2026)
- Evaluation and forecast the overall market size, and corresponding market share analysis by testing method, component, application, technology, end-user industry, and geographic region
- Highlights of the impact of COVID-19 on the progress of this market
- Review of key technology developments, latest market trends, and other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics, and chemicals
- Insight into recent industry structure, current competitive scenario, R&D activities, and regulatory and legislative issues currently focused on in vitro toxicology
- Descriptive company profiles of the leading market players including Charles River Laboratories, Evotec, Frontage Labs, ICON PLC, Medpace, PPD Inc., and Syneos Health
CHAPTER 1 INTRODUCTION
Trends in the Global Market for CRO Services
Study Goals and Objectives
What's New in the Report?
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET DYNAMICS
Market Drivers
Rising R&D Investment
Market Restraints
Lack of Skilled Professionals
Challenges in CRO Outsourcing
Market Opportunities
Inorganic Strategies
Emerging Markets
CHAPTER 4 IMPACT OF COVID-19
Overview of COVID-19 Crisis
Impact of COVID-19 on the Market for CROs
Clinical Trial Delays
Current Outlook
CHAPTER 5 OVERVIEW: CLINICAL TRIAL PROCESS AND CRO FUNCTIONAL SERVICES
Clinical Trial Process and Stages
Pre-discovery Stage
Drug Discovery
Preclinical
Clinical Stage
Phase I
Phase II
Phase III
Post-marketing Surveillance and Phase IV Studies
Regulatory Environment
FDA Regulation and Impact
Regulations on Sponsor Activities
The Declaration of Helsinki
CDISC Standards
Current Market Trends
Existing Drugs for New Indications
Increased Competition
CHAPTER 6 GLOBAL MARKET OVERVIEW
Global Clinical Trials in Asia-Pacific
CHAPTER 7 EMERGING TRENDS
Increasing Complexity of Clinical Trials
Small Molecule vs. Biologics
Biosimilars
Adaptive Design Clinical Trials
Risk-Based Monitoring
Real World Evidence
CHAPTER 8 MARKET BREAKDOWN BY REGION
Overview
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 9 COMPETITIVE LANDSCAPE
Functional Service Provider Relationships
Offshoring
Therapeutic Areas in Drug Development
Immuno-oncology
Current Pharma/CRO Contracts
Largest Therapeutic Areas Rely on Key CRO Expertise
CHAPTER 10 MERGERS AND ACQUISITIONS
CHAPTER 11 COMPANY PROFILES
Top 11 CROs
CHARLES RIVER LABORATORIES
EVOTEC
FRONTAGE LABS
ICON PLC
IQVIA
LABORATORY CORP. OF AMERICA HOLDINGS
MEDPACE
PAREXEL
PPD INC.
SYNEOS HEALTH
WUXI APPTEC
Other CROs
EPS INTERNATIONAL HOLDINGS CO. LTD.
EUROFINS SCIENTIFIC
PSI
SGS SA
CHAPTER 12 APPENDIX: ABBREVIATIONS AND ACRONYMS
Trends in the Global Market for CRO Services
Study Goals and Objectives
What's New in the Report?
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET DYNAMICS
Market Drivers
Rising R&D Investment
Market Restraints
Lack of Skilled Professionals
Challenges in CRO Outsourcing
Market Opportunities
Inorganic Strategies
Emerging Markets
CHAPTER 4 IMPACT OF COVID-19
Overview of COVID-19 Crisis
Impact of COVID-19 on the Market for CROs
Clinical Trial Delays
Current Outlook
CHAPTER 5 OVERVIEW: CLINICAL TRIAL PROCESS AND CRO FUNCTIONAL SERVICES
Clinical Trial Process and Stages
Pre-discovery Stage
Drug Discovery
Preclinical
Clinical Stage
Phase I
Phase II
Phase III
Post-marketing Surveillance and Phase IV Studies
Regulatory Environment
FDA Regulation and Impact
Regulations on Sponsor Activities
The Declaration of Helsinki
CDISC Standards
Current Market Trends
Existing Drugs for New Indications
Increased Competition
CHAPTER 6 GLOBAL MARKET OVERVIEW
Global Clinical Trials in Asia-Pacific
CHAPTER 7 EMERGING TRENDS
Increasing Complexity of Clinical Trials
Small Molecule vs. Biologics
Biosimilars
Adaptive Design Clinical Trials
Risk-Based Monitoring
Real World Evidence
CHAPTER 8 MARKET BREAKDOWN BY REGION
Overview
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 9 COMPETITIVE LANDSCAPE
Functional Service Provider Relationships
Offshoring
Therapeutic Areas in Drug Development
Immuno-oncology
Current Pharma/CRO Contracts
Largest Therapeutic Areas Rely on Key CRO Expertise
CHAPTER 10 MERGERS AND ACQUISITIONS
CHAPTER 11 COMPANY PROFILES
Top 11 CROs
CHARLES RIVER LABORATORIES
EVOTEC
FRONTAGE LABS
ICON PLC
IQVIA
LABORATORY CORP. OF AMERICA HOLDINGS
MEDPACE
PAREXEL
PPD INC.
SYNEOS HEALTH
WUXI APPTEC
Other CROs
EPS INTERNATIONAL HOLDINGS CO. LTD.
EUROFINS SCIENTIFIC
PSI
SGS SA
CHAPTER 12 APPENDIX: ABBREVIATIONS AND ACRONYMS
LIST OF TABLES
Summary Table: Global Market for CRO Services Throughout The Clinical Trial Process, by Functional Service, Through 2026
Table 1: R&D Investment in the Global Market for CRO Services, 2019 and 2020
Table 2: Leading CROs in India
Table 3: Notable Delayed and Cancelled Clinical Trials
Table 4: Likelihood of Approval, by Major Disease Area and Phase
Table 5: Clinical Phase Description
Table 6: New Drug Approvals in the Global Biopharmaceuticals Market, 2006-2021
Table 7: Approved Drugs Repurposed for Infectious Diseases
Table 8: Global Market for CRO Services, by Functional Service, Through 2026
Table 9: R&D Pipelines
Table 10: Global Small Molecule and Biologic FDA Drug Approvals, 2010-2020
Table 11: FDA-Approved Small Molecule and Biologic Drugs, Through 2022
Table 12: Global Market for CRO Services, by Region, Through 2026
Table 13: North American Market for CRO Services, by Functional Service, Through 2026
Table 14: European Market for CRO Services, by Functional Service, Through 2026
Table 15: Asia-Pacific Clinical Trial Regulations
Table 16: Asia-Pacific Market for CRO Services, by Functional Service, Through 2026
Table 17: Rest of the World Market for CRO Services, by Functional Service, Through 2026
Table 18: Key Players in Therapeutic Areas
Table 19: Pharma and CRO Partnership Alliances
Table 20: Recent M&As in CROs and Pharma Outsourcing Sector
Table 21: Deals in CRO Sector: Improving Capital Markets Leading to More IPOs
Table 22: Service Offerings, Major CROs
Table 23: Charles River Laboratories: Revenues, 2018-2020
Table 24: Evotec: Revenues, 2018-2020
Table 25: Frontage Labs: Revenue, 2018-2020
Table 26: ICON PLC: Revenue, 2018-2020
Table 27: IQVIA: Revenues, 2018-2020
Table 28: Labcorp: Revenue, 2018-2020
Table 29: Medpace: Revenues, 2018-2020
Table 30: PPD Inc.: Revenue, 2018-2020
Table 31: Syneos Health: Revenue, 2018-2020
Table 32: WuXi AppTec: Revenue, 2018-2020
Table 33: Eurofins Scientific: Revenue, 2018-2020
Table 34: SGS SA: Revenue, 2018-2020
Table 35: Abbreviations Used in This Report
Summary Table: Global Market for CRO Services Throughout The Clinical Trial Process, by Functional Service, Through 2026
Table 1: R&D Investment in the Global Market for CRO Services, 2019 and 2020
Table 2: Leading CROs in India
Table 3: Notable Delayed and Cancelled Clinical Trials
Table 4: Likelihood of Approval, by Major Disease Area and Phase
Table 5: Clinical Phase Description
Table 6: New Drug Approvals in the Global Biopharmaceuticals Market, 2006-2021
Table 7: Approved Drugs Repurposed for Infectious Diseases
Table 8: Global Market for CRO Services, by Functional Service, Through 2026
Table 9: R&D Pipelines
Table 10: Global Small Molecule and Biologic FDA Drug Approvals, 2010-2020
Table 11: FDA-Approved Small Molecule and Biologic Drugs, Through 2022
Table 12: Global Market for CRO Services, by Region, Through 2026
Table 13: North American Market for CRO Services, by Functional Service, Through 2026
Table 14: European Market for CRO Services, by Functional Service, Through 2026
Table 15: Asia-Pacific Clinical Trial Regulations
Table 16: Asia-Pacific Market for CRO Services, by Functional Service, Through 2026
Table 17: Rest of the World Market for CRO Services, by Functional Service, Through 2026
Table 18: Key Players in Therapeutic Areas
Table 19: Pharma and CRO Partnership Alliances
Table 20: Recent M&As in CROs and Pharma Outsourcing Sector
Table 21: Deals in CRO Sector: Improving Capital Markets Leading to More IPOs
Table 22: Service Offerings, Major CROs
Table 23: Charles River Laboratories: Revenues, 2018-2020
Table 24: Evotec: Revenues, 2018-2020
Table 25: Frontage Labs: Revenue, 2018-2020
Table 26: ICON PLC: Revenue, 2018-2020
Table 27: IQVIA: Revenues, 2018-2020
Table 28: Labcorp: Revenue, 2018-2020
Table 29: Medpace: Revenues, 2018-2020
Table 30: PPD Inc.: Revenue, 2018-2020
Table 31: Syneos Health: Revenue, 2018-2020
Table 32: WuXi AppTec: Revenue, 2018-2020
Table 33: Eurofins Scientific: Revenue, 2018-2020
Table 34: SGS SA: Revenue, 2018-2020
Table 35: Abbreviations Used in This Report
LIST OF FIGURES
Summary Figure: Global Market for CRO Services Throughout The Clinical Trial Process, by Functional Service, 2019-2026
Figure 1: Likelihood of Approval, by Disease Area
Figure 2: Phase II Transition Success Rates, by Disease Area
Figure 3: Phase III Transition Success Rates, by Disease Area
Figure 4: Phase IV Transition Success Rates, by Disease Area
Figure 5: Drug Approval Timeline
Figure 6: Size and Growth of the Global Market for CRO Services, 2019-2026
Figure 7: Pharma R&D Spending, 2016-2026
Figure 8: Global Prescription Drug Sales, 2016-2026
Figure 9: Global Market Shares of CRO Services, by Functional Service, 2020
Figure 10: Global Market Shares of CRO Services throughout the Clinical Trial Process, by Phase, 2020
Figure 11: Global Market for CRO Services, by Region, 2020-2026
Figure 12: Global Market Shares of CRO Services, by Region, 2020
Figure 13: Initiation of Clinical Trials in North America, by Year and Phase, 2014-2019
Figure 14: North American Market for CRO Services, 2020-2026
Figure 15: Initiation of Clinical Trials in Europe, by Year and Phase, 2014-2019
Figure 16: European Market for CRO Services, 2020-2026
Figure 17: Initiation of Clinical Trials in Asia-Pacific, by Year and Phase, 2014-2019
Figure 18: Asia-Pacific Market for CRO Services, 2020-2026
Figure 19: Initiation of Clinical Trials in Rest of the World, by Year and Phase, 2014-2019
Figure 20: Rest of the World Market for CRO Services, 2020-2026
Figure 21: Global Market Shares of CRO Services, by Company, 2020
Figure 22: Leading CRO Market Shares of Preclinical Trials, by Company, 2020
Figure 23: Leading CRO Market Shares of Clinical Trials, by Company, 2020
Figure 24: Global Therapeutic Clinical Pipeline, by Therapeutic Area, 2020
Figure 25: Expanding Value, Outsourcing Deals Involving CROs, 2007-2017
Figure 26: Charles River Laboratories: Revenue Share, by Segment, 2020
Figure 27: Evotec: Revenue Share, by Segment, 2020
Figure 28: Frontage Labs: Revenue Share, by Segment, 2020
Figure 29: IQVIA: Revenue Share, by Segment, 2020
Figure 30: Labcorp: Revenue Share, by Segment, 2020
Figure 31: PPD Inc.: Revenue Share, by Segment, 2020
Figure 32: Syneos Health: Revenue Share, by Segment, 2020
Figure 33: WuXi AppTec: Revenue Share, by Segment, 2020
Figure 34: Eurofins Scientific: Revenue Share, by Segment, 2020
Figure 35: SGS SA: Revenue Share, by Segment, 2020
Summary Figure: Global Market for CRO Services Throughout The Clinical Trial Process, by Functional Service, 2019-2026
Figure 1: Likelihood of Approval, by Disease Area
Figure 2: Phase II Transition Success Rates, by Disease Area
Figure 3: Phase III Transition Success Rates, by Disease Area
Figure 4: Phase IV Transition Success Rates, by Disease Area
Figure 5: Drug Approval Timeline
Figure 6: Size and Growth of the Global Market for CRO Services, 2019-2026
Figure 7: Pharma R&D Spending, 2016-2026
Figure 8: Global Prescription Drug Sales, 2016-2026
Figure 9: Global Market Shares of CRO Services, by Functional Service, 2020
Figure 10: Global Market Shares of CRO Services throughout the Clinical Trial Process, by Phase, 2020
Figure 11: Global Market for CRO Services, by Region, 2020-2026
Figure 12: Global Market Shares of CRO Services, by Region, 2020
Figure 13: Initiation of Clinical Trials in North America, by Year and Phase, 2014-2019
Figure 14: North American Market for CRO Services, 2020-2026
Figure 15: Initiation of Clinical Trials in Europe, by Year and Phase, 2014-2019
Figure 16: European Market for CRO Services, 2020-2026
Figure 17: Initiation of Clinical Trials in Asia-Pacific, by Year and Phase, 2014-2019
Figure 18: Asia-Pacific Market for CRO Services, 2020-2026
Figure 19: Initiation of Clinical Trials in Rest of the World, by Year and Phase, 2014-2019
Figure 20: Rest of the World Market for CRO Services, 2020-2026
Figure 21: Global Market Shares of CRO Services, by Company, 2020
Figure 22: Leading CRO Market Shares of Preclinical Trials, by Company, 2020
Figure 23: Leading CRO Market Shares of Clinical Trials, by Company, 2020
Figure 24: Global Therapeutic Clinical Pipeline, by Therapeutic Area, 2020
Figure 25: Expanding Value, Outsourcing Deals Involving CROs, 2007-2017
Figure 26: Charles River Laboratories: Revenue Share, by Segment, 2020
Figure 27: Evotec: Revenue Share, by Segment, 2020
Figure 28: Frontage Labs: Revenue Share, by Segment, 2020
Figure 29: IQVIA: Revenue Share, by Segment, 2020
Figure 30: Labcorp: Revenue Share, by Segment, 2020
Figure 31: PPD Inc.: Revenue Share, by Segment, 2020
Figure 32: Syneos Health: Revenue Share, by Segment, 2020
Figure 33: WuXi AppTec: Revenue Share, by Segment, 2020
Figure 34: Eurofins Scientific: Revenue Share, by Segment, 2020
Figure 35: SGS SA: Revenue Share, by Segment, 2020
